Trial: 202102043

A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

Phase

I/II (Cancer Control)

Principal Investigator

Pedersen, Katrina

Disease Site

Colon; Metastatic Disease; Rectum

Learn more about this study at: clinicaltrials.gov